Relevant Publications



Relevant Publications by the Investigators:

 

  1. Trucco SM, Jaeggi E, Cuneo B, Moon-Grady AJ, Silverman E, Silverman N, Hornberger LK. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol. 2011 Feb 8;57(6):715-23
  2. Kelly EN, Sananes R, Chiu-Man C, Silverman ED, Jaeggi E. Prenatal anti-Ro antibody exposure, congenital complete atrioventricular heart block, and high-dose steroid therapy: impact on neurocognitive outcome in school-age children. Arthritis Rheumatol. 2014 Aug;66(8):2290-6
  3. Chockalingam P, Jaeggi ET, Rammeloo LA, Haak MC, Adama van Scheltema PN, Breur JM, Bartelings MM, Clur SA, Blom NA. Persistent fetal sinus bradycardia associated with maternal anti-SSA/Ro and anti-SSB/La antibodies. J Rheumatol. 2011 Dec;38(12):2682-5.
  4. Jaeggi ET, Silverman ED, Laskin C, Kingdom J, Golding F, Weber R. Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses. J Am Coll Cardiol. 2011 Mar 29;57(13):1487-92.
  5. Cuneo BF, Fruitman D, Benson DW, Ngan BY, Liske MR, Wahren-Herlineus M, Ho SY, Jaeggi E.
  6. Spontaneous rupture of atrioventricular valve tensor apparatus as late manifestation of anti-Ro/SSA antibody-mediated cardiac disease. Am J Cardiol. 2011 Mar 1;107(5):761-6.
  7. Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol. 2010 Jun 15;55(24):2778-84.
  8. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation. 2004 Sep 21;110(12):1542-8.
  9. Raboisson MJ, Fouron JC, Sonesson SE, Nyman M, Proulx F, Gamache S. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies. J Am Soc Echocardiogr. 2005.
  10. Skog A, Eliasson H, Tingström J, Källberg H, Salomonsson S; Swedish Congenital Heart Block Study Group, Sonesson SE, Wahren-Herlenius M. Long-term growth of children with autoantibody-mediated congenital heart block. Acta Paediatr. 2013 Jul; 102(7):718-26.
  11. Ambrosi A, Salomonsson S, Eliasson H, Zeffer E, Skog A, Dzikaite V, Bergman G, Fernlund E, Tingström J, Theander E, Rydberg A, Skogh T, Öhman A, Lundström U, Mellander M, Winqvist O, Fored M, Ekbom A, Alfredsson L, Källberg H, Olsson T, Gadler F, Jonzon A, Kockum I, Sonesson SE, Wahren-Herlenius M. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern. Ann Rheum Dis. 2012 Mar; 71(3):334-40.
  12. Salomonsson S, Dzikaite V, Zeffer E, Eliasson H, Ambrosi A, Bergman G, Fernlund E, Theander E, Ohman A, Rydberg A, Skogh T, Wållberg-Jonsson S, Elfving A, Fored M, Ekbom A, Lundström U, Mellander M, Winqvist O, Sonesson SE, Gadler F, Jonzon A, Wahren-Herlenius M. A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block. Scand J Immunol. 2011.
  13. Meisgen S, Östberg T, Salomonsson S, Ding B, Eliasson H, Mälarstig A, Alfredsson L, Klareskog L, Hamsten A, Olsson T, Axelsson T; Swedish Congenital Heart Block Study Group, Gadler F, Jonzon A, Sonesson SE, Kockum I, Wahren-Herlenius M. The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence. J Intern Med. 2014 Jun; 275(6):640-51.
  14. Skog A, Tingström J, Salomonsson S, Sonesson SE, Wahren-Herlenius M. Neurodevelopment in children with and without congenital heart block born to anti-Ro/SSA-positive mothers. Acta Paediatr. 2013 Jan;102(1):40-6.
  15. Nield LE, Silverman ED, Smallhorn JF, Taylor GP, Mullen JB, Benson LN, Hornberger LK. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol 2002; 40:796-802.
  16. Hornberger LK, Al Rajaa N. Spectrum of cardiac involvement in neonatal lupus. Scand J Immunol. 2010 Sep;72(3):189-9.
  17. Donofrio MT, Gullquist SD, Mehta ID, Moskowitz WB Congenital complete heart block: fetal management protocol, review of the literature, and report of the smallest successful pacemaker implantation. J Perinatol. 2004 Feb; 24(2):112-7.
  18. Krishnan AN, Sable CA, Donofrio MT. Spectrum of fetal echocardiographic findings in fetuses of women with clinical or serologic evidence of systemic lupus erythematosus. J Matern Fetal Neonatal Med. 2008 Nov; 21(11):776-82.
  19. Krishnan A, Arya B, Moak JP, Donofrio MT Outcomes of fetal echocardiographic surveillance in anti-SSA exposed fetuses at a large fetal cardiology center. Prenat Diagn. 2014 Jul 3.
  20. Glatz AC, Gaynor JW, Rhodes LA, Rychik J, Tanel RE, Vetter VL, Kaltman JR, Nicolson SC, Montenegro L, Shah MJ. Outcome of high-risk neonates with congenital complete heart block paced in the first 24 hours after birth. J Thorac Cardiovasc Surg. 2008 Sep;136(3):767-73.
  21. Cuneo BF, Lee M, Roberson D, Niksch A, Ovadia M, Parilla BV, Benson DW. A management strategy for fetal immune-mediated atrioventricular block. J Matern Fetal Neonatal Med. 2010 Dec; 23(12):1400-5.
  22. Cuneo BF, Strasburger JF, Niksch A, Ovadia M, Wakai RT.An expanded phenotype of maternal SSA/SSB antibody-associated fetal cardiac disease. J Matern Fetal Neonatal Med. 2009 Mar;22(3):233-8.
  23. Cuneo BF, Zhao H, Strasburger JF, Ovadia M, Huhta JC, Wakai RT. Atrial and ventricular rate response and patterns of heart rate acceleration during maternal-fetal terbutaline treatment of fetal complete heart block. Am J Cardiol. 2007 Aug 15; 100(4):661-5.
  24. Van Bergen AH, Cuneo BF, Davis N. Prospective echocardiographic evaluation of atrioventricular conduction in fetuses with maternal Sjögren’s antibodies. Am J Obstet Gynecol. 2004 Sep; 191(3):1014-8.
  25. Zhao H, Cuneo BF, Strasburger JF, Huhta JC, Gotteiner NL, Wakai RT. Electrophysiological characteristics of fetal atrioventricular block. J Am Coll Cardiol. 2008 Jan 1;51(1):77-84.
  26. Li Z, Strasburger JF, Cuneo BF, Gotteiner NL, Wakai RT.Giant fetal magnetocardiogram P waves in congenital atrioventricular block: a marker of cardiovascular compensation? 2004 Oct 12;110(15):2097-101.
  27. Dubin AM, Cuneo BF, Strasburger JF, Wakai RT, Van Hare GF, Rosenthal DN. Congenital junctional ectopic tachycardia and congenital complete atrioventricular block: a shared etiology? Heart Rhythm. 2005 Mar;2(3):313-5.
  28. Fayn E, Chou HA, Park D, Zavitz DH, Cuneo BF, Mahan VL, Guleçyuz M, Curran L, Lipson D, Quillen EW Jr, Petrikovsky BM, Ovadia M. Ultrasonic biophysical measurements in the normal human fetus for optimal design of the monolithic fetal pacemaker. Am J Cardiol. 2005 May 15;95(10):1267-70.
  29. Das B, Cuneo BF, Ovadia M, Strasburger JF, Johnsrude C, Wakai RT. Magnetocardiography-guided management of an unusual case of isoimmune complete atrioventricular block complicated by ventricular tachycardia. Fetal Diagn Ther. 2008;24(3):282-5

CU School of Medicine Childrens Hospital Colorado Heart Institute Colorado Institute for Maternal & Fetal Health